Homology Medicines Inc. (FIXX)
NASDAQ: FIXX
· Real-Time Price · USD
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 9:00 PM
Homology Medicines Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.26 | 1.10 | -0.07 | 0.23 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | 0.00 | -0.01 | -0.02 | -0.02 | -0.61 |
PEG Ratio | 0.00 | -0.01 | n/a | -0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | n/a | -0.00 | 0.01 |
PS Ratio | n/a | -6.14 | n/a | n/a | 0.14 | n/a | 0.80 | 0.41 | 0.50 | 0.64 | 0.78 | 1.21 | 1.44 | 1.48 | 1.04 | 0.09 |
PB Ratio | -2.84 | 1.54 | 0.26 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
P/FCF Ratio | -0.91 | -1.3 | -0.23 | -0.06 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.04 | -0.1 | -0.09 | -0.09 |
P/OCF Ratio | -0.91 | -1.31 | -0.24 | -0.06 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.04 | -0.1 | -0.09 | -0.09 |
OCF/S Ratio | n/a | 4.69 | n/a | n/a | -15.22 | n/a | -66.84 | -32.49 | -33.91 | -31.09 | -38.46 | -38.26 | -37.94 | -15.14 | -11.02 | -1.02 |
Debt / Equity Ratio | -2.52 | 1.54 | 0.40 | 0.19 | 0.02 | 0.32 | 0.24 | 0.19 | 0.17 | 0.14 | 0.10 | 0.09 | 0.14 | 0.07 | 0.06 | 0.07 |
Quick Ratio | 4.71 | 4.97 | 6.53 | 4.19 | 7.25 | 4.22 | 5.73 | 8.30 | 8.02 | 8.44 | 11.50 | 12.62 | 11.14 | 10.25 | 11.16 | 10.76 |
Current Ratio | 4.71 | 4.97 | 6.53 | 4.19 | 7.25 | 4.22 | 5.73 | 8.30 | 8.02 | 8.44 | 11.50 | 12.62 | 11.14 | 10.25 | 11.16 | 10.76 |
Asset Turnover | n/a | -0.02 | n/a | n/a | 0.00 | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.12 |
Interest Coverage | n/a | 7.38 | n/a | n/a | -6.41 | n/a | n/a | n/a | n/a | -25.9 | -59.72 | -1.18K | n/a | n/a | n/a | n/a |
Return on Equity | 2.75 | 0.35 | -0.96 | 0.02 | -0.22 | -0.37 | -0.29 | -0.19 | -0.19 | -0.15 | -0.12 | 0.35 | -0.2 | -0.15 | -0.14 | -0.01 |
Return on Assets | -0.14 | 0.02 | -0.17 | 0.01 | -0.05 | -0.24 | -0.21 | -0.15 | -0.14 | -0.12 | -0.1 | 0.30 | -0.16 | -0.13 | -0.12 | n/a |
Return on Invested Capital | -0.18 | 0.02 | -0.21 | -0.1 | -0.24 | -0.3 | -0.25 | -0.17 | -0.17 | -0.14 | -0.11 | -0.13 | -0.17 | -0.14 | -0.13 | -0.01 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -0.00 | n/a | n/a | 0.09 | n/a | -0.59 | 0.27 | 0.21 | 0.21 | 0.02 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | n/a | -1.39 | n/a | n/a | -11.37 | n/a | -98.99 | -35.97 | -41.07 | -39.34 | -34.57 | 114.84 | -41.87 | -18.25 | -13.95 | -0.04 |
Pretax Profit Margin | n/a | 10.97 | n/a | n/a | -1.52 | n/a | -82.78 | -32.47 | -41.2 | -39.39 | -34.7 | 116.79 | -41.87 | -18.25 | -13.95 | -0.04 |
Operating Profit Margin | n/a | 7.65 | n/a | n/a | -6.64 | n/a | -87.05 | -34.3 | -43.01 | -40.98 | -35.3 | -46.91 | -41.93 | -18.28 | -13.97 | -0.04 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | 12.16 | n/a | n/a | -0.89 | n/a | -86.44 | -34.02 | -42.64 | -40.18 | -34.89 | -46.91 | -39.34 | -17.03 | -13.01 | 0.03 |